Article
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis.
Oncotarget - 10 May 2015
Thomas Anish, Chen Yuanbin, Steinberg Seth M, Luo Ji, Pack Svetlana, Raffeld Mark, Abdullaev Zied, Alewine Christine, Rajan Arun, Giaccone Giuseppe, Pastan Ira, Miettinen Markku, Hassan Raffit
Abstract excerpt
Mesothelin is a cell surface glycoprotein which is highly expressed in several epithelial cancers and may have a role in cell adhesion and metastases. In this study, we used prospectively obtained clinical and pathological data to characterize mesothelin expression in advanced lung adenocarcinoma. Tissue was obtained from patients who underwent molecular profiling of potentially actionable genes on a trial of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
